Graves眼病3种药物治疗方案的成本-效果分析  

3 Therapeutical Schemes on Graves Ophthalmopathy:Cost-effectiveness Analysis

作　　者：奚月芬[1] 高芸[1] 

机构地区：[1]江苏省原子医学研究所附属江原医院,无锡市214063

出　　处：《中国药房》2006年第1期34-35,共2页China Pharmacy

摘　　要：目的研究Graves眼病(GO)3种药物治疗方案的成本-效果。方法94例GO患者分为3组,分别给予甲基强的松龙(A组)、地塞米松(B组)和强的松(C组),用成本-效果分析法进行评价。结果A、B、C组成本分别为2956.76元、2059.42元、31.09元;总有效率分别为93.94%、93.75%、51.72%;成本-效果比分别为31.47元、21.97元、0.60元;A、B组相对于C组的增量成本-效果比分别为69.30元、48.26元。结论从药物经济学角度分析,B方案治疗GO相对较好。OBJECTIVE： To Study the cost- effectiveness among 3 therapeutical schemes in the treatment of Graves ophthalmopathy. METHODS： A total of 94 cases with Graves ophthalmopathy were randomized into 3 groups, Group A was assigned to receive medrat,Group B to receive dexamethasone and Group C to receive prednisone,the outcomes were evaluated in terms of the cost- effectiveness analysis. RESULTS： The costs for Group A, B and C were 2 956.76 yuan, 2 059.42 yuan and al. 09 yuan, respectively. The total effective rates were 9a. 94%, 9a. 75% and 51.72%, respectively. The cost - effectiveness ratios were 31.47 yuan, 21.97 yuan and 0.60 yuan, respectively. The incremental cost- effectiveness ratios of Group A and B were 69.30 yuan and 48.26 yuan, respectively as against Group C. CONCLUSION： In terms of pharmacoeconomies, Group B is comparatively the best option in treating Graves ophthalmopathy.

关 键 词：GRAVES眼病 治疗方案 成本-效果分析 

分 类 号：R956[医药卫生—药学]